Table 3.
Predictors of Treatment Pattern for Chronic, Symptomatic FBDs in Multivariable Multinomial Logistic Regression
| Predictor | Pharmacologic treatment only |
Nonpharmacologic treatment only |
Combined treatment |
|||
|---|---|---|---|---|---|---|
| aOR (95% CI) | P value | aOR (95% CI) | P value | aOR (95% CI) | P value | |
| Age, per decade | 0.99 (0.88–1.13) | .91 | 0.90 (0.73–1.10) | .30 | 0.94 (0.79–1.12) | .52 |
| Male sex | 0.72 (0.45–1.13) | .15 | 1.37 (0.73–2.57) | .32 | 1.21 (0.65–2.28) | .55 |
| Nonwhite race | 0.63 (0.33–1.24) | .18 | 0.73 (0.29–1.87) | .52 | 1.10 (0.43–2.86) | .84 |
| Payment method | ||||||
| Private insurance | — | — | — | — | — | — |
| Medicare/Medicaid | 1.70(1.05–2.78) | .03 | 1.99 (0.86–4.58) | .11 | 1.85 (0.94–3.62) | .07 |
| Other | 1.22 (0.41–3.64) | .72 | 1.50 (0.42–5.31) | .53 | 1.68 (0.54–5.24) | .37 |
| US geographic region | ||||||
| Northeast | — | — | — | — | — | — |
| Midwest | 1.37 (0.75–2.51) | .30 | 1.32 (0.47–3.67) | .60 | 0.34 (0.15–0.78) | .01 |
| South | 1.27 (0.75–2.16) | .37 | 0.82 (0.35–1.93) | .65 | 0.38 (0.17–0.87) | .02 |
| West | 0.94 (0.47–1.88) | .86 | 1.30 (0.46–3.64) | .62 | 0.52 (0.19–1.37) | .18 |
| Primary care physician | 0.86 (0.51–1.45) | .57 | 1.57 (0.68–3.61) | .29 | 1.88 (1.00–3.55) | .05 |
| Health care visits in past year | ||||||
| 0 | — | — | — | — | — | — |
| 1–2 | 1.05 (0.58–1.92) | .87 | 0.62 (0.24–1.60) | .32 | 0.76 (0.32–1.82) | .54 |
| 3–6 | 2.15 (1.04–4.42) | .04 | 1.11 (0.48–2.55) | .80 | 1.47 (0.60–3.58) | .40 |
| ≥7 | 3.82 (1.70–8.58) | .001 | 0.88 (0.26–2.95) | .84 | 2.25 (0.79–6.42) | .13 |
| Depression | 1.82 (1.06–3.11) | .03 | 3.04 (1.19–7.75) | .02 | 4.33 (2.19–8.56) | <.001 |
| Obesity | 1.37 (0.68–2.76) | .37 | 2.36 (0.79–7.01) | .12 | 7.84 (3.14–19.61) | <.001 |
| Diabetes | 0.85 (0.45–1.64) | .64 | 0.75 (0.25–2.23) | .61 | 0.94 (0.39–2.26) | .89 |
NOTE. All ORs represent effect sizes compared to the base outcome reference category (no treatment). Bold values are statistically significant (P<.05).